TGFbeta induces SIK to negatively regulate type I receptor kinase signaling
Related Experiment Video
Updated: Jul 2, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Marcin Kowanetz1, Peter Lönn, Michael Vanlandewijck
1Ludwig Institute for Cancer Research, Uppsala University, Box 595 Biomedical Center, Uppsala, Sweden.
Abstract:
Signal transduction by transforming growth factor beta (TGFbeta) coordinates physiological responses in diverse cell types. TGFbeta signals via type I and type II receptor serine/threonine kinases and intracellular Smad proteins that regulate transcription. Strength and duration of TGFbeta signaling is largely dependent on a negative-feedback program initiated during signal progression. We have identified an inducible gene target of TGFbeta/Smad signaling, the salt-inducible kinase (SIK), which negatively regulates signaling together with Smad7. SIK and Smad7 form a complex and cooperate to down-regulate the activated type I receptor ALK5. We further show that both the kinase and ubiquitin-associated domain of SIK are required for proper ALK5 degradation, with ubiquitin functioning to enhance SIK-mediated receptor degradation. Loss of endogenous SIK results in enhanced gene responses of the fibrotic and cytostatic programs of TGFbeta. We thus identify in SIK a negative regulator that controls TGFbeta receptor turnover and physiological signaling.
Insights
Salt-inducible kinase (SIK) negatively regulates transforming growth factor beta (TGFbeta) signaling by targeting ALK5 receptors for degradation. Loss of SIK enhances TGFbeta-mediated fibrotic and cytostatic gene responses.
Area of Science:
- Cellular biology
- Molecular signaling
Background:
- Transforming growth factor beta (TGFbeta) signaling regulates diverse cellular functions through receptor kinases and Smad proteins.
- Negative feedback mechanisms are crucial for controlling the duration and intensity of TGFbeta signaling.
- Salt-inducible kinase (SIK) is an inducible gene target of TGFbeta/Smad signaling.
Purpose of the Study:
- To investigate the role of SIK as a negative regulator in TGFbeta signaling.
- To elucidate the mechanism by which SIK modulates TGFbeta receptor activity.
Main Methods:
- Investigated the interaction between SIK, Smad7, and the TGFbeta type I receptor ALK5.
- Assessed the requirement of SIK's kinase and ubiquitin-associated domains for ALK5 degradation.
- Utilized gene knockout models to evaluate the impact of endogenous SIK loss on TGFbeta responses.
Main Results:
- SIK forms a complex with Smad7 to down-regulate activated ALK5.
- Both the kinase and ubiquitin-associated domain of SIK are essential for ALK5 degradation, with ubiquitin enhancing the process.
- Loss of endogenous SIK leads to amplified fibrotic and cytostatic gene responses to TGFbeta.
Conclusions:
- SIK acts as a critical negative regulator of TGFbeta signaling by promoting TGFbeta receptor turnover.
- SIK's function is vital for maintaining physiological control over TGFbeta-mediated cellular processes, including fibrosis and cytostasis.
Related Concept Videos
TGF - β Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The JAK-STAT Signaling Pathway
Receptor Tyrosine Kinases
GPCR Desensitization

